These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16955379)

  • 1. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging.
    Casciani E; Gualdi GF
    Abdom Imaging; 2006; 31(4):490-9. PubMed ID: 16955379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectroscopy in prostate cancer: hope or hype?
    Roach M; Kurhanewicz J; Carroll P
    Oncology (Williston Park); 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. PubMed ID: 11758871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1H magnetic resonance spectroscopy of the prostate].
    Mueller-Lisse UG; Scherr M
    Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton MR spectroscopy of the prostate.
    Mueller-Lisse UG; Scherr MK
    Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging.
    Vilanova JC; Barceló J
    Abdom Imaging; 2007; 32(2):253-61. PubMed ID: 17476554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
    Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
    BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
    Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.
    Giusti S; Caramella D; Fruzzetti E; Lazzereschi M; Tognetti A; Bartolozzi C
    Abdom Imaging; 2010 Dec; 35(6):757-63. PubMed ID: 19756851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
    Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning.
    Wu X; Dibiase SJ; Gullapalli R; Yu CX
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1577-83. PubMed ID: 15050339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer.
    Huzjan R; Sala E; Hricak H
    Nat Clin Pract Urol; 2005 Sep; 2(9):434-42. PubMed ID: 16474681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level.
    Pickett B; Kurhanewicz J; Pouliot J; Weinberg V; Shinohara K; Coakley F; Roach M
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):65-72. PubMed ID: 16517094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer.
    Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Lisi D; Osimani M; Alfarone A; Gentilucci A; Parente U; Passariello R; Gentile V
    Cancer Invest; 2010 May; 28(4):424-32. PubMed ID: 20073578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of 3D 1H-MRS with body coil at 3T in the differential diagnosis of the prostate cancer].
    Wang F; Dai YP; Sun XZ; Guo Y; Chen YQ; Mao LJ; Wang DH; Deng CH
    Zhonghua Nan Ke Xue; 2009 May; 15(5):431-6. PubMed ID: 19514556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
    Kumar R; Nayyar R; Kumar V; Gupta NP; Hemal AK; Jagannathan NR; Dattagupta S; Thulkar S
    Urology; 2008 Oct; 72(4):859-63. PubMed ID: 18329078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D MR spectroscopic imaging in the evaluation of prostate cancer.
    Rajesh A; Coakley FV; Kurhanewicz J
    Clin Radiol; 2007 Oct; 62(10):921-9. PubMed ID: 17765456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer.
    Pickett B; Kurhanewicz J; Coakley F; Shinohara K; Fein B; Roach M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1047-55. PubMed ID: 15519774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.